Company intelligence / Profile preview

Tianjin Intelligent Health

Tianjin, Tianjin, Chinaytlak.com ↗

Ownership: Private
Development stage: Commercial

Overview

Tianjin Intelligent Health Medical has developed and commercialized China's first high voltage steep-pulse therapeutic apparatus with proprietary intellectual property rights. This device is used for clinical ablation of solid tumors such as liver and pancreatic cancers. The company also developed a CT-based surgical navigation system for precision interventional operations, both filling significant gaps in China's medical technology landscape. Clinical results are referenced but not detailed publicly; the products are described as having been successfully industrialized and applied clinically.

Therapeutic areas: Oncology
Modalities: DeviceElectroporation-based therapy (Steep-pulse ablation device)
Industry: Therapeutic Medical Devices

Partnerships

None disclosed

Beyond the preview

Go deeper on Tianjin Intelligent Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tianjin Intelligent Health.

Explore the full profile